Maria C. Carrillo
Rosario, S, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Delta-tocotrienol enhances the anti-tumor effects of interferon alpha through reactive oxygen species and Erk/MAPK signaling pathways in hepatocellular carcinoma cells.
Journal: Canadian journal of physiology and pharmacology
Published: December 21, 2021
The chemoprotective effects of IFN-α-2b on rat hepatocarcinogenesis are blocked by vitamin E supplementation.
Journal: The Journal of nutritional biochemistry
Published: December 24, 2020
Sirtuin 1 and 2 inhibitors enhance the inhibitory effect of sorafenib in hepatocellular carcinoma cells.
Journal: European journal of pharmacology
Published: June 24, 2020
Hepatic glycerol metabolism is early reprogrammed in rat liver cancer development.
Journal: Biochimie
Published: August 21, 2019
Participation of 5-lipoxygenase and LTB4 in liver regeneration after partial hepatectomy.
Journal: Scientific reports
Published: July 03, 2019
IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice.
Journal: Toxicology and applied pharmacology
Published: March 21, 2019
Vitamin K2 supplementation blocks the beneficial effects of IFN-α-2b administered on the early stages of liver cancer development in rats.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: July 05, 2018
Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines.
Journal: Toxicology letters
Published: June 23, 2017
Attenuation of liver cancer development by oral glycerol supplementation in the rat.
Journal: European journal of nutrition
Published: September 27, 2016
Hepatic carboxylesterase 3 (Ces3/Tgh) is downregulated in the early stages of liver cancer development in the rat.
Journal: Biochimica et biophysica acta
Published: June 01, 2016
Last Updated: 09/26/2026